This World Lymphoma Awareness Day, Lymphoma Canada not only raised awareness of the signs and…
adminOctober 15, 2015
A study published in the ASH Blood Journal in June 2015 reports that bretuximab vedotin…
adminSeptember 22, 2015
On September 1, Roveena and Lymphoma Canada announced that she will be joining the team…
adminSeptember 9, 2015
For immediate release September 8, 2015 ROVEENA PARTNERS WITH LYMPHOMA CANADA & LAUNCHES MUSIC VIDEO…
adminSeptember 8, 2015
Lymphoma Canada will receive a $25,000 donation to be directed toward research to improve the…
adminSeptember 2, 2015
Obinutuzumab (Gazyva) improved overall response and had acceptable toxicity compared with rituximab (Rituxan) in patients…
adminAugust 25, 2015
Brentuximab Vedotin is Effective as Salvage Therapy in Patients with Relapsed/Refractory Hodgkin Lymphoma Prior to…
adminAugust 17, 2015
Mutation patterns in seven genes may help predict outcomes for individuals with follicular lymphoma (more…)
adminAugust 10, 2015
Health Canada has issued a Notice of Compliance with Conditions (NOC/c) for ibrutinib (Imbruvica®), a…
adminJuly 31, 2015
